DUBLIN–(BUSINESS WIRE)–The “A
Practical Guide to Writing Risk Management Plans (RMPS)”
conference has been added to ResearchAndMarkets.com’s offering.
The new Pharmacovigilance Legislation of 2012 now requires companies to
provide Risk Management Plans (RMPs) and assessments for all new
products whether those products are generic products or new chemical
entities. If these are not done correctly this can delay both licensure
and sales and damage the Company ability to maximise its products.
Maintenance of the RMPs also is an important aspect for maintaining the
licence, compliance and these are reviewed in Regulatory Inspections.
Can you afford not to get this right?
This course will be relevant for anyone requiring a comprehensive
overview of the Pharmacovigilance function and duties. It may be of
particular interest to those who are responsible in Pharmacovigilance
for any safety assessments and writing such plans including any Medical
Directors who approve such plans. Those who work with pharmacovigilance,
e.g. Regulatory Affairs, Clinical, Sales &…
